Literature DB >> 6325885

Aspects of the metabolism of the epidermal growth factor receptor in A431 human epidermoid carcinoma cells.

S J Decker.   

Abstract

The biosynthesis and posttranslational metabolism of the epidermal growth factor (EGF) receptor were examined in the A431 human epidermoid carcinoma cell line. Polyclonal antibody against the receptor specifically immunoprecipitated two [35S]methionine-labeled proteins of Mr = 160,000 and 170,000. Pulse chase experiments showed the Mr = 160,000 protein to be a precursor of the Mr = 170,000 protein. Preincubation with tunicamycin resulted in immunoprecipitation of a single band of Mr = 130,000, whereas monensin inhibited maturation to the Mr = 170,000 form. Digestion of the Mr = 160,000 and 170,000 proteins with endoglycosidase H resulted in the appearance of Mr = 130,000 and 165,000 proteins, respectively. Prolonged pulse-chase experiments indicated that the half-life of the receptor is ca. 20 h in the absence of EGF and 5 h in the presence of EGF. Approximately three- to five-fold more phosphate is incorporated into the mature receptor upon addition of EGF, due primarily to increases in levels of phosphotyrosine and phosphoserine. Phosphate was also present on the Mr = 160,000 protein and the Mr = 130,000 protein found in the presence of tunicamycin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325885      PMCID: PMC368757          DOI: 10.1128/mcb.4.4.571-575.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

1.  Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular polypeptides.

Authors:  K Radke; G S Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

2.  Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells.

Authors:  J Schlessinger; Y Shechter; M C Willingham; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

Review 3.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Molecular mechanism of mitogen action: processing of receptor induced by epidermal growth factor.

Authors:  M Das; C F Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line.

Authors:  M M Wrann; C F Fox
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

7.  The specific site of tunicamycin inhibition in the formation of dolichol-bound N-acetylglucosamine derivatives.

Authors:  L Lehle; W Tanner
Journal:  FEBS Lett       Date:  1976-11-15       Impact factor: 4.124

8.  Cellular information in the genome of recovered avian sarcoma virus directs the synthesis of transforming protein.

Authors:  R E Karess; W S Hayward; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

9.  Biosynthesis and turnover of the mannose 6-phosphate receptor in cultured Chinese hamster ovary cells.

Authors:  G G Sahagian; E F Neufeld
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431.

Authors:  H T Haigler; J A McKanna; S Cohen
Journal:  J Cell Biol       Date:  1979-05       Impact factor: 10.539

View more
  14 in total

1.  Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer.

Authors:  Aleksandra Franovic; Lakshman Gunaratnam; Karlene Smith; Isabelle Robert; David Patten; Stephen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

2.  Low-density-lipoprotein receptors in human fibroblasts are not degraded in lysosomes.

Authors:  L A Casciola; K I Grant; W Gevers; G A Coetzee; D R van der Westhuyzen
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

Review 3.  Biosynthesis and metabolic degradation of receptors for epidermal growth factor.

Authors:  A M Soderquist; G Carpenter
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

4.  Nerve growth factor induces the association of a 130-Kd phosphoprotein with its receptor in PC-12 pheochromocytoma cells.

Authors:  M Ohmichi; S J Decker; A R Saltiel
Journal:  Cell Regul       Date:  1991-09

5.  Biosynthesis and glycosylation of the epidermal growth factor receptor in human tumor-derived cell lines A431 and Hep 3B.

Authors:  C R Carlin; B B Knowles
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

6.  Accelerated degradation of 160 kDa epidermal growth factor (EGF) receptor precursor by the tyrosine kinase inhibitor herbimycin A in the endoplasmic reticulum of A431 human epidermoid carcinoma cells.

Authors:  Y Murakami; S Mizuno; Y Uehara
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

7.  Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptor.

Authors:  I A McKay; P Malone; C J Marshall; A Hall
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

8.  Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors.

Authors:  L Beguinot; J A Hanover; S Ito; N D Richert; M C Willingham; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Nerve growth factor stimulates a novel protein kinase in PC-12 cells that phosphorylates and activates mitogen-activated protein kinase kinase (MEK).

Authors:  L Pang; C F Zheng; K L Guan; A R Saltiel
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

10.  Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor.

Authors:  D W Fry; A J Bridges; W A Denny; A Doherty; K D Greis; J L Hicks; K E Hook; P R Keller; W R Leopold; J A Loo; D J McNamara; J M Nelson; V Sherwood; J B Smaill; S Trumpp-Kallmeyer; E M Dobrusin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.